Press Release: Molly S. Stumacher, MD, Represents Pennsylvania with Inclusion into Renowned Publication The Leading Physicians of the World

The International Association of Healthcare Professionals has carefully selected Molly S. Stumacher, MD, to represent oncology in their publication, The Leading Physicians of the World. Dr. Stumacher’s selection is a significant representation of her passion and dedication for the field of oncology.  She is considered to be among the best in her years in practice. Dr. Stumacher serves the Chester County Hospital in West Chester, Pennsylvania. Working for a branch of the hospital called Chester County Hematology/Oncology, Dr. Stumacher and her team strive to perform the best care possible for their patients, treating them like a member of their own family.  Board certified in internal medicine, hematology and oncology, Dr. Stumacher treats patients with cancers and/or various blood disorders.  She was named a Top Doc in Main Line Today magazine in 2009, 2010 and 2011.  The author of an article in the Journal of Clinical Oncology, Dr. Stumacher was also honored by Vitals.com as a Compassionate Doctor and Patients’ Choice Award in the year of 2011. In 2000, Dr. Stumacher attended the prestigious Harvard Medical School and received her MD there.  She then completed her residency in Internal Medicine at Brigham and Women’s Hospital in Boston, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania.  In 2004-2005, she was elected Chief Fellow in Hematology-Oncology. To find out more about Dr. Stumacher, please visit www.cchosp.com [1] and molly-stumacher.findatopdoc.com [2]. Also be sure to look out for her upcoming publication in The Leading Physicians of the World. To find a doctor in your area, please visit www.findatopdoc.com [3].

[1] http://www.cchosp.com
[2] http://www.molly-stumacher.findatopdoc.com
[3] http://www.findatopdoc.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.